vita capital iv

Risk Management Solutions (RMS) has provided some details on the risk analysis undertaken for the recent Vita Capital IV Ltd. mortality catastrophe bond issued by Swiss Re. The press release from RMS follows below.

Swiss Re have announced completion of their latest issuance under the Vita Capital mortality catastrophe bond scheme. The latest two series of notes have been issued under Vita Capital IV Ltd. and enables Swiss Re to transfer $175m of extreme mortality risk to the capital markets.

Swiss Re have begun marketing for two new series of mortality catastrophe bond notes to be issued by the Vita Capital IV Ltd. special purpose vehicle which is domiciled in the Cayman Islands. These two series of notes will add to the two series Swiss Re issued through Vita Capital IV in the last twelve […]

Various sources are reporting that Swiss Re is preparing to launch a fourth excess mortality transaction under its Vita series. Vita Capital IV is said to be a $75m mortality bond, it started as $50m but demand has been high and the deal has upsized significantly. It’s assumed that Vita Capital IV will replace a […]